Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019



Thomas Fellner

Thomas Fellner

Head of Cell & Gene Therapy, Lonza Pharma & Biotech

Dr. Thomas Fellner is Head of Commercial Development for Cell Therapy at the Lonza Group, a Swiss company, headquartered in Basel, Switzerland.  Since 1987, Lonza has been a leading custom manufacturer and developer, offering global services and products ranging from active pharmaceutical ingredients and stem-cell therapies to our clients globally. 

In his current role, Dr. Fellner is responsible for the strategic development and planning, portfolio management, and business development for the cell therapy business. Previously, as Director of the Pluripotent Stem Cell Research team, Dr. Fellner was responsible for the development of new technologies, providing a comprehensive service offering to assist our clients, bridge the gap from research to cell therapy.  

Before joining Lonza, Dr. Fellner was an integral part of the Human Embryonic Stem Cell Program at the University of California, San Diego (UCSD), USA. He gained his expertise in stem cell biology through appointments at Stanford University, USA and the University of California in Los Angeles (UCLA), USA. Dr. Fellner holds an MBA degree from the Rady School of Management at UCSD and a Ph.D. degree in Biochemistry from the University of Vienna, Austria.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd